experimental group x-MAP
1.0
Phase 2 other active
Quick answer
experimental group x-MAP for Metastatic Colorectal Cancer (mCRC) is a Phase 2 program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Metastatic Colorectal Cancer (mCRC)
- Phase
- Phase 2
- Modality
- other
- Status
- active